
Passage Bio’s Exciting Upcoming Investor Appearances: Get the Inside Scoop!
Passage Bio’s Upcoming Investor Conferences: What Does it Mean for the Company and the World of Genetic Medicines? Philadelphia, PA, February 26, 2025 – Passage Bio, Inc., a pioneering clinical-stage genetic medicines company focusing on enhancing the lives of patients grappling with neurodegenerative diseases, recently shared some exciting news with the investment community. In an…